Search
Search Results
##search.searchResults.foundPlural##
-
-
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1374PDF: 1303HTML: 96 -
TUBERCULOSIS IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS.
2622PDF: 940HTML: 3603 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
1821PDF: 714HTML: 2105Untitled: 214Untitled: 152Untitled: 170Untitled: 154Untitled: 163Untitled: 176Untitled: 183 -
COST OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN INDIA
2662PDF: 966HTML: 4702 -
NURSING MANAGEMENT OF HAEMORRHAGIC CYSTITIS IN PATIENTS UNDERGOING HAEMATOPOIETIC STEM CELL TRANSPLANTATION: A MULTICENTRE ITALIAN SURVEY Nursing management of haemorrhagic cystitis
1848PDF: 1045HTML: 245 -
PEDIATRIC TUBERCULOSIS IN THE NORTH SARDINIA
2457PDF: 855HTML: 2384 -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
4076PDF: 1237HTML: 1953Table 1: 194 -
EFFECT OF FRESH VERSUS CRYOPRESERVED GRAFTS ON FEBRILE NEUTROPENIA AND INFECTIONS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION: FACTORS DETERMINING MORTALITY. Fresh vs Frozen Grafts: Infection and Outcome
797PDF: 527HTML: 80 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
2388PDF: 912HTML: 491
1 - 25 of 25 items







